The efficacy of PET-CT for predicting the malignant potential of gastrointestinal stromal tumors

Abstract

Gastrointestinal stromal tumor (GIST) is the most common sarcoma of the intestinal tract. The risk category is usually determined by tumor size and mitotic count, but accurate preoperative diagnosis of GIST is very difficult. The purpose of this study is to evaluate the efficacy of positron emission tomography(PET)-CT for predicting the malignant potential of gastrointestinal stromal tumors. Ten patients with GIST who underwent a preoperative PET-CT examination were divided into two groups by risk category, and various factors were compared between the two groups. The relationships between the maximum standardized uptake value (SUVmax) and GIST parameters were examined. Patients were classified into two groups by their risk category: (low/intermediate-risk or high-risk). The SUVmax was significantly higher in the high-risk group (11.0±3.04) than in the low/intermediate-risk group (2.1±1.5). The Ki67 labeling index was also significantly higher in the high-risk group (8.63±6.2) than in the low/intermediate-risk group (1.75±0.52). There was a significant correlation between the Ki67 labeling index and the SUVmax (p=0.028) and between the mitotic index and the SUVmax (p=0.029). PET-CT can predict malignant potential. Cases with a SUVmax of over 5 may have malignant potential.